Answers are grounded in this paper and cite their sources.
Saddle pulmonary embolism (SPE) is a proximal imaging phenotype of acute pulmonary embolism, characterised by a continuous thrombus that traverses the main pulmonary artery bifurcation, commonly with extension into both main pulmonary arteries. Imaging establishes thrombus location and continuity but not physiological severity. Some cohorts associate saddle morphology with right ventricular (RV) involvement or adverse events. Adjusted findings are inconsistent, however, and added prognostic value beyond established clinical and physiological markers remains unproven. This review examines what saddle morphology adds to pulmonary embolism (PE) assessment and where evidence remains insufficient. We conducted a structured narrative review using iterative, topic-focused searches; the initial searches covered publications from inception to May 2026, followed by a documented update performed from 29 September to 1 October 2026 covering publications through 30 September 2026, with no language restriction applied. PubMed/MEDLINE was the primary source, supplemented by Web of Science Core Collection, Google Scholar and citation tracking. Evidence was appraised by design, SPE specificity, comparator, baseline severity, confounding, endpoint type, precision and follow-up. We separate direct SPE evidence from general-PE or mechanistic extrapolation and distinguish technical or physiological, management-sensitive and patient-important outcomes. Saddle morphology should prompt assessment rather than assign a risk category; thrombus burden alone does not classify risk. We operationalise an imaging-enhanced framework in which computed tomography pulmonary angiography (CTPA) triggers assessment of haemodynamics, RV imaging, biomarkers and bleeding risk, maps patients to established PE categories and uses clinical trajectory to guide escalation. Anticoagulation remains the cornerstone. Reperfusion, surgery and extracorporeal support are reserved for high-risk, deteriorating or carefully selected patients; inferior vena cava filters remain limited to established indications unrelated to saddle morphology. SPE is best regarded as an alerting imaging phenotype rather than a distinct high-risk category. The proposed framework is an evidence-informed organisational model, not a validated prediction rule or treatment algorithm. Whether this framework improves multidisciplinary assessment remains untested. Prospective SPE-specific studies must establish the added prognostic value of morphology and whether morphology-informed care improves patient-important outcomes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: